GO:0070640 vitamin D3 metabolic process: Activation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070640 (vitamin D3 metabolic process) describes the chemical reactions and pathways involving vitamin D3 (cholecalciferol), including its synthesis, transport, and enzymatic activation.
• Vitamin D3 is produced in the skin from 7-dehydrocholesterol upon UVB exposure and is also obtained from diet; it then enters the circulation bound to vitamin D binding protein.
• Full biological activity requires two sequential hydroxylations: hepatic 25-hydroxylation to calcidiol and renal 1-alpha-hydroxylation to calcitriol, the active hormone.
• In vitro multi-compartment liver-kidney organ-on-chip platforms have been used to model the metabolic activation of vitamin D3, confirming the sequential two-step process.
• Vitamin D3 metabolic process is critical for calcium homeostasis, bone health, immune function, and has been linked to neurodegenerative diseases such as multiple sclerosis, Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis.
• Dysregulation of vitamin D3 metabolism is associated with metabolic syndrome, skeletal muscle injury, and nephroprotection, with studies showing vitamin D3 potentiates metformin and telmisartan effects via AMPK/SIRT1 and PPAR-gamma/GLUT4 pathways.
Description
GO:0070640, vitamin D3 metabolic process, is a biological process ontology term that encompasses the chemical reactions and pathways involving vitamin D3 (cholecalciferol), a secosteroid hormone precursor. Vitamin D3 is unique among vitamins because it can be synthesized endogenously in the skin from 7-dehydrocholesterol upon exposure to ultraviolet B radiation, in addition to being absorbed from dietary sources. Once formed or ingested, vitamin D3 undergoes a series of enzymatic transformations that convert it into its biologically active form, 1,25-dihydroxyvitamin D3 (calcitriol), which acts as a potent regulator of calcium and phosphate homeostasis, bone metabolism, and immune function. Understanding the vitamin D3 metabolic process is essential for researchers across endocrinology, nutrition, neuroscience, and pharmacology. The pathway involves multiple organs, including skin, liver, and kidney, and is mediated by cytochrome P450 enzymes such as CYP2R1 and CYP27B1. Dysregulation of this process has been implicated in a wide range of pathologies, from metabolic syndrome and skeletal muscle injury to neurodegenerative diseases including multiple sclerosis, Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis. Moreover, the bioavailability of vitamin D3 from dietary sources and its transport in circulation are critical determinants of its physiological impact. Recent advances in microfluidic organ-on-chip technology have enabled researchers to recapitulate the liver-kidney metabolic activation of vitamin D3 in vitro, providing new tools to study this pathway and its regulation. Comparative studies have also demonstrated that vitamin D3 (cholecalciferol) is more efficacious than vitamin D2 (ergocalciferol) in regulating calcium absorption and bone quality, underscoring the importance of understanding the specific metabolic fate of vitamin D3. This article provides a comprehensive overview of GO:0070640, covering its definition, molecular mechanisms, key genes, disease associations, and modern research methodologies including CRISPR-based models.
vitamin D3 metabolic process At A Glance
| GO ID | GO:0070640 |
|---|---|
| GO term | vitamin D3 metabolic process |
| Ontology | biological_process |
| Synonym | calciol metabolic process; cholecalciferol metabolic process; vitamin D3 metabolism |
| Major function | Conversion of vitamin D3 to active calcitriol and regulation of calcium/phosphate homeostasis |
| Key organs | Skin, liver, kidney |
| Key enzymes | CYP2R1, CYP27B1, CYP24A1 |
| Related diseases | Metabolic syndrome, neurodegenerative diseases, skeletal muscle injury, nephroprotection |
| Research models | Organ-on-chip, rat models, CRISPR knockout/knock-in cell models |
What Is GO:0070640?
GO:0070640 (vitamin D3 metabolic process) is defined by the Gene Ontology as the chemical reactions and pathways involving vitamin D3, (3S,5Z,7E)-9,10-secocholesta-5,7,10(19)-trien-3-ol. This includes the synthesis of vitamin D3 in the skin from 7-dehydrocholesterol, its transport in the bloodstream, and its enzymatic conversion to active metabolites such as 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3. The term also encompasses the catabolism and degradation of vitamin D3 and its metabolites. Synonyms include calciol metabolic process, cholecalciferol metabolic process, and vitamin D3 metabolism.
Why Is vitamin D3 metabolic process Important in Cell Biology?
The vitamin D3 metabolic process is fundamental to human health because it governs the production of calcitriol, the active hormone that regulates calcium absorption, bone mineralization, immune function, and cellular differentiation. Disruptions in this pathway are linked to a spectrum of disorders, including rickets, osteoporosis, metabolic syndrome, and neurodegenerative conditions. Moreover, vitamin D3 metabolism influences drug efficacy, as shown by its ability to potentiate metformin and telmisartan in preclinical models. Understanding this process at the molecular level is therefore critical for developing targeted therapies and for interpreting vitamin D status in clinical and research settings.
• Regulates calcium and phosphate homeostasis, essential for bone health and neuromuscular function.
• Produces calcitriol, a hormone with broad effects on immune response, cell proliferation, and differentiation.
• Dysregulation is associated with neurodegenerative diseases such as multiple sclerosis, Parkinson's disease, Alzheimer's disease, and ALS.
• Vitamin D3 metabolism impacts metabolic syndrome and skeletal muscle injury, with therapeutic implications.
• Bioavailability and transport of vitamin D3 affect its physiological efficacy and are influenced by dietary and genetic factors.
• In vitro organ-on-chip models enable detailed study of liver-kidney metabolic activation, reducing reliance on animal models.
• Vitamin D3 is more efficacious than vitamin D2 in regulating calcium absorption and bone quality, highlighting the importance of the specific metabolic pathway.
• The pathway is a target for drug interactions, as vitamin D3 potentiates metformin and telmisartan effects via AMPK/SIRT1 and PPAR-gamma/GLUT4 axes.
• Understanding vitamin D3 metabolism aids in designing nutritional and therapeutic interventions for at-risk populations.
• CRISPR-based models allow precise dissection of gene function in vitamin D3 metabolism, accelerating discovery.
What Happens During vitamin D3 metabolic process?
Synthesis and Dietary Uptake
In simple terms: Vitamin D3 is made in the skin from sunlight or absorbed from food.
Vitamin D3 (cholecalciferol) is synthesized endogenously in the skin from 7-dehydrocholesterol upon exposure to UVB radiation, and it is also obtained from dietary sources such as fatty fish and fortified foods. The bioavailability of dietary vitamin D3 depends on factors including food matrix and lipid absorption. Once formed or ingested, vitamin D3 is incorporated into chylomicrons or bound to vitamin D binding protein for transport.
Transport in Circulation
In simple terms: Vitamin D3 travels in the blood attached to a carrier protein.
After synthesis in the skin or absorption from the gut, vitamin D3 is transported in the bloodstream bound primarily to vitamin D binding protein (DBP) and to a lesser extent albumin. This transport process is essential for delivering vitamin D3 to the liver for further metabolism. Studies using radiolabeled vitamin D3 have characterized the translocation process from skin into circulation, revealing rapid appearance in plasma.
Hepatic 25-Hydroxylation
In simple terms: The liver adds a hydroxyl group to vitamin D3 to make calcidiol.
In the liver, vitamin D3 is hydroxylated at the C-25 position by cytochrome P450 enzymes, primarily CYP2R1, to form 25-hydroxyvitamin D3 (calcidiol). This is the major circulating form of vitamin D and is used clinically to assess vitamin D status. The reaction requires NADPH and molecular oxygen.
Renal 1-Alpha-Hydroxylation
In simple terms: The kidney activates calcidiol into the active hormone calcitriol.
In the kidney, 25-hydroxyvitamin D3 is further hydroxylated at the C-1alpha position by CYP27B1 to produce 1,25-dihydroxyvitamin D3 (calcitriol), the biologically active form. This step is tightly regulated by parathyroid hormone, calcium, and phosphate levels. Organ-on-chip studies have confirmed that this two-step activation can be modeled in vitro using liver and kidney compartments.
Catabolism and Inactivation
In simple terms: The body breaks down active vitamin D to prevent excess.
Calcitriol and its precursors can be inactivated by 24-hydroxylation, catalyzed by CYP24A1, leading to excretion. This catabolic pathway is induced by calcitriol itself as a negative feedback mechanism to maintain vitamin D homeostasis. Dysregulation of catabolism can lead to vitamin D deficiency or toxicity.
Key Genes Involved in GO:0070640 vitamin D3 metabolic process
The following genes encode enzymes, transport proteins, and receptors that are central to the vitamin D3 metabolic process.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CYP2R1 | 25-hydroxylase; converts vitamin D3 to calcidiol | Target for knockout studies to assess vitamin D status |
| CYP27B1 | 1-alpha-hydroxylase; produces active calcitriol | Knockout models develop rickets; key for activation studies |
| CYP24A1 | 24-hydroxylase; inactivates vitamin D metabolites | Overexpression models study catabolism and toxicity |
| VDR | Vitamin D receptor; mediates genomic effects of calcitriol | Knockout mice reveal broad physiological roles |
| DBP (GC) | Vitamin D binding protein; transports vitamin D metabolites | Polymorphisms affect bioavailability and disease risk |
| CYP3A4 | Alternative 25-hydroxylase in liver | Contributes to vitamin D metabolism; drug interactions |
| CYP2J2 | Alternative 25-hydroxylase | Extrahepatic vitamin D metabolism |
| CYP27A1 | Alternative 25-hydroxylase | Mitochondrial vitamin D metabolism |
| LRP2 (Megalin) | Renal reabsorption of vitamin D binding protein | Knockout models show urinary loss of vitamin D |
| CUBN (Cubilin) | Cofactor for megalin in vitamin D uptake | Implicated in vitamin D deficiency |
| NADSYN1 | NAD synthetase; linked to vitamin D metabolism | GWAS associations with vitamin D levels |
| DHCR7 | 7-dehydrocholesterol reductase; affects substrate availability | Knockout increases vitamin D3 synthesis |
| CYP11A1 | Cholesterol side-chain cleavage; alternative vitamin D activation | Extrarenal calcitriol production |
| FGF23 | Regulates phosphate and vitamin D metabolism | Knockout models show altered calcitriol levels |
| PTH | Parathyroid hormone; stimulates CYP27B1 | Regulates calcium and vitamin D activation |
| SLC34A1 | Sodium-phosphate cotransporter; linked to vitamin D metabolism | Mutations cause hypophosphatemic rickets |
| KL (Klotho) | Cofactor for FGF23 signaling | Knockout models display vitamin D dysregulation |
| CYP24A1 | Catabolic enzyme; 24-hydroxylase | Mutations cause idiopathic infantile hypercalcemia |
How Is vitamin D3 metabolic process Regulated?
The vitamin D3 metabolic process is tightly regulated at multiple levels. Renal 1-alpha-hydroxylation by CYP27B1 is stimulated by parathyroid hormone (PTH), low calcium, and low phosphate, and inhibited by FGF23 and calcitriol itself. Conversely, CYP24A1, which catabolizes calcitriol, is induced by calcitriol via VDR, providing negative feedback. Transport and bioavailability are influenced by vitamin D binding protein (DBP) and megalin-mediated uptake in the kidney. Additionally, metabolic syndrome and drugs such as metformin and telmisartan can modulate vitamin D3 metabolism through AMPK/SIRT1 and PPAR-gamma/GLUT4 pathways.
vitamin D3 metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CYP27B1 | Vitamin D-dependent rickets type I | Knockout mouse; patient-derived iPSCs |
| CYP2R1 | Vitamin D-dependent rickets type IB | Knockout cell lines; organ-on-chip |
| VDR | Hereditary vitamin D-resistant rickets | Knockout mice; overexpression models |
| CYP24A1 | Idiopathic infantile hypercalcemia | Knockout models; catabolism assays |
| DBP (GC) | Vitamin D deficiency; altered bioavailability | Knockout mice; transport studies |
Neurodegenerative Diseases
Vitamin D3 metabolic process has been linked to neurodegenerative diseases including multiple sclerosis (MS), Parkinson's disease (PD), Alzheimer's disease (AD), and amyotrophic lateral sclerosis (ALS). Epidemiological studies suggest that vitamin D deficiency is associated with increased risk and severity of these conditions, although causality remains under investigation. The active metabolite calcitriol exerts neuroprotective effects through anti-inflammatory and immunomodulatory actions.
Metabolic Syndrome and Skeletal Muscle Injury
Dysregulation of vitamin D3 metabolism contributes to metabolic syndrome, a cluster of conditions including obesity, insulin resistance, and hypertension. In rat models, vitamin D3 supplementation potentiates the nephroprotective effects of metformin via AMPK/SIRT1 activation and DPP-4 inhibition. Additionally, vitamin D3 ameliorates skeletal muscle injury in metabolic syndrome through PPAR-gamma/AT1 receptor/GLUT4 axis modulation.
Bone and Mineral Disorders
Impaired vitamin D3 metabolism leads to rickets, osteomalacia, and osteoporosis due to reduced calcium absorption. Vitamin D3 is more efficacious than vitamin D2 in regulating calcium absorption and bone quality, highlighting the importance of the specific metabolic pathway. Genetic defects in CYP27B1 or CYP2R1 cause vitamin D-dependent rickets.
From vitamin D3 metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does CYP2R1 knockout affect vitamin D status? | CRISPR knockout HepG2 or primary hepatocytes |
| What is the effect of a point mutation in CYP27B1 on enzyme activity? | Point-mutation knock-in HEK293 cells |
| Can tagged CYP24A1 be used to track catabolism? | Knock-in with fluorescent tag in renal cells |
| Does VDR overexpression alter vitamin D target gene expression? | Overexpression in osteoblast-like cells |
| What is the role of DBP in vitamin D transport? | Knockout mouse or CRISPR DBP-null cell line |
| Can organ-on-chip model liver-kidney activation? | Multi-compartment microfluidic device |
How to Study the vitamin D3 metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| LC-MS/MS | Vitamin D metabolite concentrations | Quantification in serum and cell culture |
| Organ-on-chip | Liver-kidney metabolic activation | In vitro modeling of vitamin D3 activation |
| CRISPR knockout | Gene function loss | Identifying essential metabolic genes |
| CRISPR knock-in | Tagged protein expression | Tracking enzyme localization and dynamics |
| RNA-seq | Transcriptional changes | Vitamin D target gene discovery |
| Proteomics | Protein expression and modifications | Pathway analysis in metabolic syndrome |
| Immunoassay | 25(OH)D levels | Clinical vitamin D status assessment |
LC-MS/MS for Vitamin D Metabolites
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is the gold standard for quantifying vitamin D3 and its metabolites (25(OH)D3, 1,25(OH)2D3) in biological samples. This method provides high sensitivity and specificity, enabling precise measurement of metabolic flux in cell culture and animal models.
Organ-on-Chip Platforms
Multi-compartment microfluidic liver-kidney organ-on-chip platforms have been developed to model the sequential activation of vitamin D3 in vitro. These systems allow real-time monitoring of metabolite conversion and can incorporate patient-derived cells for personalized studies.
CRISPR Screening and Gene Editing
CRISPR knockout, knock-in, and point-mutation models enable functional dissection of genes involved in vitamin D3 metabolism. Library screening can identify novel regulators of the pathway, while bioinformatics integrates genomic and metabolomic data.
Transcriptomics and Proteomics
RNA-seq and proteomics can reveal changes in gene expression and protein abundance in response to vitamin D3 metabolites. These approaches help identify downstream targets and regulatory networks.
How CRISPR Can Be Used to Study GO:0070640 vitamin D3 metabolic process
Knockout
CRISPR knockout of genes such as CYP2R1, CYP27B1, or VDR in cell lines (e.g., HepG2, HEK293) allows researchers to study loss-of-function effects on vitamin D3 metabolism. These models are valuable for validating drug targets and understanding disease mechanisms.
Point Mutation
Introducing specific point mutations (e.g., in CYP27B1 or CYP24A1) via CRISPR base editing or HDR can mimic human genetic variants associated with vitamin D-dependent rickets or hypercalcemia. Such models help assess enzyme activity and substrate specificity.
Knock-in
Knock-in of fluorescent or epitope tags (e.g., GFP-CYP24A1) enables real-time tracking of enzyme localization and turnover in live cells. This approach is useful for studying the dynamic regulation of vitamin D metabolism.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of genes like VDR or CYP24A1 can model gain-of-function states and assess downstream effects on calcium homeostasis and gene expression. Overexpression models are also used to study drug interactions.
How EDITGENE Supports vitamin D3 metabolic process Research
Researchers studying vitamin D3 metabolic process-related genes often need to determine whether a candidate gene is causally involved in metabolite conversion, transport, or receptor signaling. EDITGENE provides comprehensive CRISPR-based services to accelerate this discovery, from knockout to precise point mutations and overexpression models.
Contact EDITGENE today to design your custom CRISPR model for vitamin D3 metabolic process research.
Frequently Asked Questions About vitamin D3 metabolic process
What is GO:0070640 vitamin D3 metabolic process?
GO:0070640 is a Gene Ontology biological process term describing the chemical reactions and pathways involving vitamin D3 (cholecalciferol), including its synthesis, transport, and enzymatic activation to calcitriol.
What genes are involved in vitamin D3 metabolic process?
Key genes include CYP2R1, CYP27B1, CYP24A1, VDR, and DBP (GC), which encode enzymes and transport proteins essential for vitamin D3 metabolism.
How is vitamin D3 activated in the body?
Vitamin D3 is activated by two sequential hydroxylations: first in the liver by CYP2R1 to form calcidiol, then in the kidney by CYP27B1 to form calcitriol, the active hormone.
What diseases are linked to vitamin D3 metabolic process?
Dysregulation is associated with neurodegenerative diseases (MS, PD, AD, ALS), metabolic syndrome, skeletal muscle injury, rickets, and osteoporosis.
Can CRISPR be used to study vitamin D3 metabolism?
Yes, CRISPR knockout, knock-in, and point mutation models enable functional studies of genes like CYP27B1 and VDR in cell lines and organoids.
What is the difference between vitamin D3 and vitamin D2 metabolism?
Vitamin D3 (cholecalciferol) is more efficacious than vitamin D2 (ergocalciferol) in regulating calcium absorption and bone quality, partly due to differences in metabolic activation.
How is vitamin D3 transported in the blood?
Vitamin D3 is transported bound primarily to vitamin D binding protein (DBP) and albumin, which deliver it to target tissues.
What are common research methods for studying vitamin D3 metabolism?
LC-MS/MS, organ-on-chip platforms, CRISPR screening, RNA-seq, and proteomics are widely used to study vitamin D3 metabolic process.
What is the role of CYP24A1 in vitamin D3 metabolism?
CYP24A1 catalyzes the 24-hydroxylation of vitamin D metabolites, leading to their inactivation and excretion, thus regulating vitamin D homeostasis.
How does metabolic syndrome affect vitamin D3 metabolism?
Metabolic syndrome can alter vitamin D3 metabolism, and vitamin D3 supplementation has been shown to potentiate metformin and telmisartan effects via AMPK/SIRT1 and PPAR-gamma/GLUT4 pathways.
Conclusion
GO:0070640 vitamin D3 metabolic process is a vital biological pathway that governs the activation and regulation of vitamin D3, impacting calcium homeostasis, bone health, immune function, and neurological well-being. Understanding its molecular mechanisms, key genes, and disease associations is essential for developing targeted therapies and nutritional interventions. Advances in CRISPR-based models and organ-on-chip technologies are accelerating research in this field, offering new opportunities to dissect gene function and identify novel therapeutic targets. EDITGENE provides comprehensive CRISPR services to support these discoveries, from knockout to overexpression and library screening.
References
- 1. Borel P et al.. 2015. Vitamin D bioavailability: state of the art.. Crit Rev Food Sci Nutr 55(9):1193-205 PMID: 24915331
- 2. DeLuca HF. 2004. Overview of general physiologic features and functions of vitamin D.. Am J Clin Nutr 80(6 Suppl):1689S-96S PMID: 15585789
- 3. Savran Z et al.. 2025. Vitamin D and Neurodegenerative Diseases Such as Multiple Sclerosis (MS), Parkinson's Disease (PD), Alzheimer's Disease (AD), and Amyotrophic Lateral Sclerosis (ALS): A Review of Current Literature.. Curr Nutr Rep 14(1):77 PMID: 40464816
- 4. Wahba NS et al.. 2021. Vitamin D3 potentiates the nephroprotective effects of metformin in a rat model of metabolic syndrome: role of AMPK/SIRT1 activation and DPP-4 inhibition.. Can J Physiol Pharmacol 99(6):685-697 PMID: 33108744
- 5. Theobald J et al.. 2019. In vitro metabolic activation of vitamin D3 by using a multi-compartment microfluidic liver-kidney organ on chip platform.. Sci Rep 9(1):4616 PMID: 30874583
- 6. Tian XQ et al.. 1994. Characterization of the translocation process of vitamin D3 from the skin into the circulation.. Endocrinology 135(2):655-61 PMID: 8033813
- 7. Dutta S et al.. 2025. Vitamin D3 (cholecalciferol) is more efficacious than Vitamin D2 (ergocalciferol) at regulating calcium absorption and bone quality in rats.. J Steroid Biochem Mol Biol 254:106837 PMID: 40712802
- 8. Wahba NS et al.. 2025. Telmisartan and/or vitamin D3 ameliorate skeletal muscle injury in a rat model of metabolic syndrome: A new insight into PPAR-γ/AT(1) receptor/GLUT4 axis.. Eur J Pharmacol 1002:177845 PMID: 40516847
